Jump Financial’s Ocular Therapeutix OCUL Stock Holding History

Jump Financial’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.4M	Buy	401,833 +228,040	+131%	+$2.17M	0.05%	459
2025 Q4	$2.11M	Buy	173,793 +111,569	+179%	+$1.36M	0.03%	653
2025 Q3	$727K	Buy	+62,224	New	+$744K	0.01%	1142
2024 Q3	–	Sell	-123,442	Closed	-$844K	–	1982
2024 Q2	$844K	Buy	123,442 +80,123	+185%	+$495K	0.02%	898
2024 Q1	$394K	Buy	+43,319	New	+$307K	0.01%	1305
2023 Q3	–	Sell	-220,300	Closed	-$1.14M	–	2136
2023 Q2	$1.14M	Buy	220,300 +108,300	+97%	+$644K	0.04%	615
2023 Q1	$590K	Buy	+112,000	New	+$532K	0.02%	817
2021 Q4	–	Sell	-60,300	Closed	-$603K	–	1617
2021 Q3	$603K	Sell	60,300 -17,011	-22%	-$191K	0.04%	430
2021 Q2	$1.1M	Buy	+77,311	New	+$1.18M	0.11%	254
2020 Q4	–	Sell	-16,200	Closed	-$123K	–	1113
2020 Q3	$123K	Buy	+16,200	New	+$134K	0.02%	682

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Jump Financial's OCUL Position: Q1 2026 in Review

Jump Financial increased its Ocular Therapeutix (OCUL) stake by 131% in Q1 2026, buying an estimated $2.17M and bringing the position to 401,833 shares worth $3.4M. The position accounts for 0.05% of the portfolio, ranked #459.

Jump Financial first reported a position in OCUL in Q3 2020 and has held it in 10 quarters since. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

Jump Financial held 401,833 shares of Ocular Therapeutix worth $3.4M as of Q1 2026.
Jump Financial bought 228,040 Ocular Therapeutix shares in Q1 2026, an estimated $2.17M.
Ocular Therapeutix made up 0.05% of Jump Financial's portfolio in Q1 2026, its #459 holding.
Jump Financial first reported a position in Ocular Therapeutix in Q3 2020 and has held it in 10 quarters since.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.